Cervical adenocarcinoma and squamous cell carcinoma incidence trends among tunisian women

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 3, 2010, Pages 777-780

  Missaoui, Nabiha ^a,b   Trabelsi, Amel ^b   Landolsi, Hanène ^b   Jaidaine, Lilia ^b   Mokni, Moncef ^b   Korbi, Sadok ^b   Hmissa, Sihem ^a,b  

^a Medicine Faculty   (Tunisia)

^b F Hached University Hospital   (Tunisia)

Author keywords

Cancer; Cervix uteri; Epidemiology; Incidence; Tunisia

Indexed keywords

EID: 78650694348     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Arbyn M, Autier P, Ferlay J (2007). Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol, 18, 1423-5.
2. Arbyn M, Geys H (2002). Trend of cervical cancer mortality in Belgium (1954-1994): Tentative solution for the certification problem of unspecified uterine cancer. Int J Cancer, 102, 649-54.
3. Belot A, Grosclaude P, Bossard N, et al (2008). Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique, 56, 159-75.
4. Ben Youssef R, Maalej M, Ben Youssef L, et al (1987). Cancer of the cervix uteri in Tunisia. Clinical presentation and development over a 10-year period. J Gynecol Obstet Biol Reprod, 16, 63-7.
5. Bergström R, Sparén P, Adami HO (1999). Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer, 81, 159-66.
6. Bray F, Carstensen B, Møller H, et al (2005). Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev, 14, 2191-9.
7. Bray F, Wibe A, Dørum LM, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 74, 74-108.
8. Bray F, Guilloux A, Sankila R, et al (2002). Practical implications of imposing a new world standard population. Cancer Causes Control, 13, 175-82.
9. Bulk S, Visser O, Rozendaal L, et al (2005). Cervical cancer in the Netherlands 1989-1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer, 113, 1005-9.
10. Castellsagué X, Díaz M, de Sanjosé S, et al (2006). Bosch, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group, Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst, 98, 303-15.
11. Chen JG, Zhu J, Parkin DM, et al (2006). Trends in the incidence of cancer in Qidong, China, 1978-2002. Int J Cancer, 119, 1447-54.
12. Comber H, Gavin A (2004). Recent trends in cervical cancer mortality in Britain and Ireland: the case for populationbased cervical cancer screening. Br J Cancer, 91, 1902-4.
13. Curado MP, Edwards B, Shin HR, et al (2007). Cancer Incidence in Five Continents, Vol. IX. Lyon: IARC Scientific Publications, No. 160.
14. Dargent D (1999). Cancer of the uterine cervix. Epidemiology, pathologic anatomy, diagnostic evolution, principles of treatment, staging. Rev Prat, 49, 1923-33.
15. Eifel PJ, Burke TW, Morris M, et al (1995). Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage 1B cervical carcinoma. Gynecol Oncol, 59, 38-44.
16. Eifel PJ, Morris M, Oswald MJ, et al (1990). Adenocarcinoma of the uterine cervix: prognosis and patterns of failure in 367 Cases. Cancer, 65, 2507-14.
17. Gien LT, Beauchemin MC, Thomas G (2010). Adenocarcinoma: A unique cervical cancer. Gynecol Oncol, 116, 140-6.
18. Howlett RI, Marrett LD, Innes MK, et al (2007). Decreasing incidence of cervical adenocarcinoma in Ontario: is this related to improved endocervical Pap test sampling. Int J Cancer, 120, 362-7.
19. Jin F, Devesa SS, Chow WH, et al (1999). Cancer incidence trends in urban shanghai, 1972-1994: an update. Int J Cancer, 83, 435-40.
20. Krane JF, Granter SR, Trask CE, et al (2001). Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases. Cancer, 93, 8-15.
21. Levi F, Lucchini F, Negri E, et al (2000). The decline in cancer mortality in the European Union, 1988-1996. Eur J Cancer, 36, 1965-8.
22. Maalej M, Mrad K, Kochbati L, et al (2004). Cervical cancer in Tunisia: an epidemiological, clinical and pathological study. Eur J Obstet Gynecol Reprod Biol, 113, 226-8.
23. Mathew A, George PS (2009). Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix-worldwide. Asian Pacific J Cancer Prev, 10, 645-50.
24. Muñoz N, Franceschi S, Bosetti C, et al (2002). Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet, 359, 1093-101.
25. Murthy NS, Chaudhry K, Saxena S (2005). Trends in cervical cancer incidence-Indian scenario. Eur J Cancer Prev, 14, 513-8.
26. Parkin DM, Ferlay J, Hamdi-Chérif M, et al (2003). Cancer in Africa, Epidemiology and prevention. IARC Sci Publ, 153, 1-414.
27. Percy C, Van Holten V, Muir C (1992). International classification of diseases for oncology, World Health Organization, Geneva.
28. Sankaranarayanan R, Budukh AM, Rajkumar R (2001). Effective screening programmes for cervical cancer in low-and middle-income developing countries. Bull World Hlth Organ, 79, 954-62.
29. Sasieni P, Adams J (2001). Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet, 357, 1490-3.
30. Sherman ME, Wang SS, Carreon J, et al (2005). Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer, 103, 1258-64.
31. Smith HO, Tiffany MF, Qualls CR, et al (2000). The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: a 24-year population-based study. Gynecol Oncol, 78, 97-105.
32. Taylor R, Morrell S, Mamoon H, et al (2006). Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia). Cancer Causes Control, 17, 299-306.
33. Van der Aa MA, Pukkala E, Coebergh JW, et al (2008). Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer, 122, 1854-8.
34. Visioli CB, Zappa M, Ciatto S (2004). Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Program, 1985-2000. Cancer Detect Prev, 28, 461-4.
35. Vizcaino AP, Moreno V, Bosch FX (2000). International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer, 86, 429-35.
36. Vizcaino AP, Moreno V, Bosch FX (1998). International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer, 75, 536-45.
37. Wang SS, Sherman ME, Hildesheim A (2004). Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer, 100, 1035-44.
38. Yang L, Parkin DM, Li L (2003). Time trends in cancer mortality in China: 1987-1999. Int J Cancer, 106, 771-83.
39. Zur Hausen H (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer, 2, 342-50.